Questions about data manipulation [GxP / QC / QA]

posted by qualityassurance – 2024-04-30 13:38 (20 d 17:12 ago) – Posting: # 23967
Views: 1,882

Dear Forum members,

❝ Dr. Anders Fuglsang has developed several software programs to detect such manipulation.

Is it advisable that CRO use this software (after implementing the SOP within the system) and prove that no such manipulation was done during BE study. By this way both sponsors and CROs are relaxed and regulatory authority will also have readily available data from the software.
The idea behind above approach is, there is no other way of finding such manipulation (profile duplication) during routine QA review or monitoring by sponsor.


Complete thread:

UA Flag
 Admin contact
23,033 posts in 4,835 threads, 1,647 registered users;
40 visitors (0 registered, 40 guests [including 4 identified bots]).
Forum time: 06:51 CEST (Europe/Vienna)

Give me a fruitful error any time, full of seeds, bursting with its own corrections.
You can keep your sterile truth for yourself.    Vilfredo Pareto

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz